Entrada Therapeutics, Inc. (TRDA)

Entrada Therapeutics Stock Forecast

Stock Price Forecast

The 2 analysts with 12-month price forecasts for Entrada Therapeutics stock have an average target of 20, which predicts a 66.67% increase from the current stock price of 12.

Price Target: $20 (+66.67%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$20	$20	$20	$20
Change	+66.67%	+66.67%	+66.67%	+66.67%

Analyst Ratings

The average analyst rating for Entrada Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Oct '25	Nov '25	Dec '25	Jan '26	Feb '26	Mar '26
Strong Buy	2	2	2	2	2	2
Buy	1	1	1	1	0	0
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	3	3	3	3	2	2

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Raghuram Selvaraju HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $20	Strong Buy	Reiterates	$20	+66.67%	Feb 18, 2026
Debjit Chattopadhyay Guggenheim	Guggenheim	Strong Buy Initiates $20	Strong Buy	Initiates	$20	+66.67%	Feb 11, 2026
Raghuram Selvaraju HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $20	Strong Buy	Reiterates	$20	+66.67%	May 20, 2025
Raghuram Selvaraju HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $20	Strong Buy	Reiterates	$20	+66.67%	Mar 31, 2025
Raghuram Selvaraju HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $20	Strong Buy	Reiterates	$20	+66.67%	Feb 25, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

38.48M

Increased by 51.37%

from 25.42M

Revenue Next Year

56.56M

Increased by 46.98%

from 38.48M

EPS This Year

-4.28

from -3.47

EPS Next Year

-4.40

from -4.28

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	-	-	129.01M	210.78M	25.42M	38.48M	56.56M
Revenue Growth	-	-	-	63.38%	-87.94%	51.37%	46.98%
EPS	-8.16	-3.02	-0.20	1.68	-3.47	-4.28	-4.40
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	8	6

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027	2028	2029	2030
High	63.0M	89.3M
Avg	38.5M	56.6M
Low	14.7M	25.4M

Revenue Growth

Revenue Growth	2026	2027	2028	2029	2030
High	147.8%	131.9%
Avg	51.4%	47.0%
Low	-42.2%	-34.0%

EPS Forecast

EPS	2026	2027	2029	2030
High	-3.18	-3.35
Avg	-4.28	-4.40
Low	-4.83	-4.97

EPS Growth

EPS Growth	2026	2027	2029	2030
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.